OBJECTIVE: This study intended to investigate disturbances in b-adrenergically-mediated substrate utilization and thermogenesis in obese subjects with mild non insulin-dependent diabetes mellitus (NIDDM). DESIGN: Following a baseline period of 30 min, the b-agonist isoproterenol (ISO) was administered in increasing doses of 6, 12, and 24 ngakg FFM .min, each dose for 30 min. SUBJECTS: Nine healthy lean males (CON, 50.6 AE 2.4 y, % body fat: 16.0 AE 1.8) and 10 obese subjects with NIDDM (51.8 AE 2.4 y, % body fat 34.1 AE 1.9). RESULTS: Basal non esteri®ed fatty acid concentrations (NEFA) and basal fat oxidation (absolute or expressed per unit fat free mass, FFM) were signi®cantly higher in NIDDM as compared to CON, whereas basal carbohydrate (CHO) oxidation was signi®cantly lower. The ISO-induced increase in NEFA-concentrations was blunted in NIDDM (D at 24 ngakg FFM .min: CON: 717 AE 59 mmolal vs NIDDM: 358 AE 97 mmolal, P`0.01). The non-protein respiratory exchange ratio (RER) did not change in NIDDM and signi®cantly decreased in CON during ISO-infusion (P`0.05), re¯ecting the tendency towards a blunted increase in fat oxidation in NIDDM (D fat ox at 24 ng; CON: 0.025 AE 0.005 gamin vs NIDDM 0.016 AE 0.007 gamin). The ISO-induced thermogenic response was comparable in NIDDM and CON (at 24 ng %increase above baseline: CON: 16.8 AE 2.2% vs NIDDM: 14.7 AE 0.9%). At all time points, there were no signi®cant differences in circulating ISO and noradrenaline concentrations. Basal adrenaline (A) concentrations and A concentrations during ISO-infusion were signi®cantly lower in NIDDM (basal A; CON: 64 AE 15 pgaml vs NIDDM: 25 AE 2 pgaml, P`0.001). CONCLUSION: There appear to be deviations in b-adrenoceptor mediated fat utilization and adrenal medulla function in obesity-associated NIDDM. The impairments in sympathetically mediated fat utilization have previously been observed in`simple' obese subjects, indicating that these disturbances are con®ned to the obese state per se.
Introduction
The development of (abdominal) obesity is strongly linked to the development of non insulin-dependent diabetes mellitus (NIDDM), hypertension and dyslipidaemia. 1, 2 Obesity and obesity-associated NIDDM type 2 diabetes are associated with disturbances in the utilization of fat as a fuel during b-adrenergic stimulation or catecholamine infusion. 3 ± 7 Firstly, resistance of lipolysis to sympathetic stimulation has been reported in obese subjects 6, 7 and in subcutaneous adipocytes (`in vitro') of upper-body obese subjects with hypertension, dyslipidaemia and insulin resistance (IR) or mild NIDDM. 4 Secondly, a diminished catecholamine induced oxidation of fat has been observed in obese subjects, 3,5 ± 7 which was due to an impaired uptake and utilization of non-esteri®ed fatty acids (NEFA) by skeletal muscle. 6, 7 This diminished utilization of NEFA was proposed to favour fat storage over oxidation and so predispose towards obesity. On the other hand, it is suggested that this diminished muscle NEFA uptake may increase the NEFA supply to the liver, thereby promoting a decreased insulin binding to hepatocytes and an increased hepatic VLDL synthesis. Thus, these deviations in sympathetically mediated fat utilization may provide a link between the obese state and the development of IR and NIDDM. For this reason, it is of special interest to obtain more information on possible defects in b-adrenoceptor mediated fat utilization in obese subjects with mild NIDDM.
So far, most studies have focussed on the thermogenic response to infusion of exogenous catecholamines. It was suggested that a decreased response to stimulation of the sympathetic nervous system via badrenoceptors may be of importance in the impaired diet-induced thermogenesis of obesity. 8 This may be a factor contributing to a decreased energy cost of weight maintenance and may thereby be of importance in the development and maintenance of excess body weight. Reports on the impaired thermogenesis in obesity are, however, controversial, which may be due to a large heterogeneity in response. 4, 9 The importance of any accompanying diabetes for the thermogenic response to sympathetic stimuli was demonstrated in a report showing that obese diabetic women failed to increase their energy expenditure (EE) during mild cold exposure. 10 A diminished sympathetically mediated thermogenesis in obesityassociated NIDDM would correspond to the ®nding that hyperinsulinaemia results in a decreased adrenaline-induced thermogenesis. 11 On the other hand, insulin has been suggested to stimulate the sympathetic nervous system and thermogenesis 1 and IR is a feature of obesity and NIDDM. Hence, an interaction between the degree of IR, sympathetic activity and thermogenesis is possible.
Thus, as indicated above, previous studies in our laboratory showed deviations in b adrenergically mediated fat utilization in obese males, 6 ,7 whereas b-adrenoceptor mediated thermogenesis was not signi®cantly different from controls, 6 due to a large heterogeneity in response in the obese group. 9 The impairments in fat utilization may be of importance in the etiology of obesity and IR. The present study was designed to investigate whether similar defects in badrenoceptor fat utilization are present in obese subjects with mild NIDDM, by comparing them to a healthy non-obese control group.
Subjects and methods
The subjects were nine healthy lean males (CON) and 10 obese subjects with NIDDM, of (on average) 2 y and 4 months duration (range 0.5 ± 8 y). The diabetic subjects were treated with diet alone (n 3) or together with sulphonylurea (n 7). All diabetic subjects had good blood glucose control (HbA 1c 6.6 AE 0.3%, range 5.6 ± 8.3%, normal range 4.4 ± 6.2%). Besides the blood glucose lowering medication, no other medication was used. No subjects had serious health problems, apart from their diabetes. A normal resting electrocardiogram (ECG) and a normal blood pressure (diastolic blood pressure (DBP) 95 mmHg) were prerequisites for participation in the study. Subject characteristics are indicated in Table 1 . All subjects participated for no more than 3 h per week in sports, and none had a physically demanding job. The study protocol was reviewed and approved by the Medical Ethical Review Committee of Maastricht University, and all subjects provided written consent.
Body composition
Body weight was determined on an electronic scale. Circumference measurements to the nearest 1 cm were made with the subject standing upright. Waist circumference was measured, in each subject, midway between the lower rib margin and the iliac crest at the end of a gentle expiration. The hip circumference was determined at the level of the widest circumference over the great trochanters.
Body composition was determined by hydrostatic weighing with simultaneous lung volume measurement (Volugraph 2000, Mijnhardt, The Netherlands). Body composition was calculated according to the formula of Siri.
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Isoproterenol (ISO) infusion test
In the type 2 diabetic NIDDM subjects, medication was stopped two days before the experiment. For the measurement of the b-adrenergically mediated metabolic responses, subjects fasted from 20.00 h the evening before, but were allowed to drink water freely. The experiment started at 08.00 h, and subjects came to the laboratory by car or by bus. Room temperature was kept between 23 ± 25 C. At the start of the experiment, two canullae were inserted in the left and right antecubital veins. The experiment was started 30 min after the insertion of the canullae. Following a 30 min baseline measurement, the bagonist ISO was intravenously infused in increasing doses of 6, 12 and 24 ngakgffm.min, with each dose administered for 30 min. The dose is related to ISO sulphate, 69% of which corresponds to ISO free base. Whole body EE was determined by an open-circuit ventilated hood system (Oxycon Beta, Mijnhardt, The Netherlands). During the experiment, heart rate (HR) was recorded continuously by means of a three-lead ECG. When heart rate had increased by 30 bpm or in case of frequent irregularities in ECG, the ISO-infusion was stopped. At the end of each infusion period, venous blood samples were taken for the determination of catecholamines, non-esteri®ed fatty acids, glucose and insulin. For the determination of catecholamines, a blood sample was taken in a heparinized syringe and was put into a glutathione-containing tube on ice.
For the determination of the other metabolites, blood was taken in syringes containing EDTA. The samples were immediately centrifuged at 3000 rpm at 4 C, and were put into liquid nitrogen and subsequently stored at 7 80 C. Concentration of ISO, noradrenaline (NA) and adrenaline (A) were determined by high-performance liquid chromatography (HPLC) with use of internal standards. 13 Plasma NEFA and glucose were measured using standard enzymatic techniques automated on the Cobas Bio centrifugal analyzer at 340 nm (for NEFA: NEFA C, 
Results
After 10 min of ISO infusion, thermogenic and heart rate responses reached a steady state, that is, 5 min values remained stable until the end of the experiment (Figure 1, left panel) . Therefore, mean values for the Figure 1 Five-minute values for energy expenditure (EE), heart rate, O 2 -consumption and CO 2 production, during stepwise infusion of increasing doses of the non-selective b-agonist isoproterenol (ISO). CON Control; NIDDM non insulin-dependent diabetes mellitus. Figure 2 indicates the changes in plasma concentration of ISO, NA and A during ISO infusion. The increase in plasma ISO during ISO-infusion (P`0.01) tended to be higher in NIDDM, but differences between groups did not reach statistical signi®-cance (interaction group-repeated measures, P 0.10). Basal NA concentrations were not signi®cantly different between groups. ISO resulted in a dose-related increase in plasma NA levels in both groups (P`0.001) and this increase was more pronounced in NIDDM as compared to CON (interaction group-repeated measures, P`0.05). Concentrations of adrenalin were signi®cantly lower in NIDDM as compared to CON during rest and during ISO infusion (effect of NIDDM, P`0.05, at all time points P`0.05). There was a slight decrease in plasma A in CON (P`0.05), whereas values in NIDDM did not change. Figure 3 shows values for insulin, glucose and NEFA. In both groups, there was a signi®cant increase in insulin as result of ISO-infusion (P`0.01). Basal insulin concentrations, as well as the ISO-induced Beta-adrenergic stimulation, obesity and type 2 diabetes EE Blaak et al increase in insulin, were signi®cantly higher in NIDDM compared to CON (effect of NIDDM, P 0.001, interaction group-repeated measures, P`0.001). As expected, glucose concentrations were signi®cantly higher in NIDDM compared to CON, throughout the experiment (effect of NIDDM, P`0.01, at all time points P`0.05). During ISOinfusion, there was a signi®cant decrease of glucose in NIDDM (P`0.05), whereas values did not change in CON. Plasma NEFA concentrations signi®cantly increased during ISO-infusion in both groups (P`0.001). Basal NEFA concentrations were signi®-cantly increased in NIDDM (P`0.05), whereas the ISO-induced increase in NEFA concentrations was signi®cantly blunted in NIDDM (interaction grouprepeated measures, P`0.01), resulting in comparable NEFA concentrations during the ISO-infusion. Figure 4 represents values for EE, non protein RER and substrate utilization. Resting EE (REE) was signi®cantly higher in NIDDM, compared to CON (5.96 AE 0.32 kJamin vs 5.08AE 0.24 kJamin, P`0.01), according to the increased FFM in NIDDM. There were no sign®cant differences in slopes and intercepts for the regression lines of REE vs FFM between both groups, indicating that REE adjusted for FFM is comparable in both groups (ANCOVA, (NS)). The thermogenic response to ISO-infusion was not significantly different between CON and NIDDM, either expressed per kg FFM (Figure 4 ) or as % increase above basal (at 24 ngakg FFM.min; CON: 16.8AE 2.2% vs NIDDM: 14.7AE 0.9%, NS).
The ratio between fat and CHO oxidation, re¯ected by the non protein RER, was signi®cantly lower during rest in NIDDM compared to CON (Figure 4 , P`0.05). Non protein RER signi®cantly decreased in CON (P`0.05), whereas in NIDDM, there were no signi®cant differences (Figure 4) . At the ISO infusion dose of 6 ngakg FFM.min, nonprotein RER was still signi®cantly lower in NIDDM compared to CON (P`0.05), whereas at 12 ng and 24 ng there were no signi®cant differences between groups.
Resting CHO oxidation, either expressed as absolute values (CON: 0.099AE 0.02 gamin vs NIDDM: 0.053AE 0.21 gamin) or per kg FFM (Figure 4) , was signi®cantly lower in NIDDM compared to CON (P`0.05), whereas the opposite was seen for basal fat oxidation (CON: 0.056AE 0.01 gamin vs NIDDM 0.095AE 0.01 gamin, P`0.05, Figure 4 ). CHO oxidation did not signi®cantly change during ISO-infusion in CON, whereas there was a tendency towards an increase in NIDDM (P 0.055, Figure 4 ). At all time points during ISO-infusion, CHO oxidation, expressed per FFM, was signi®cantly lower in NIDDM as compared to CON (P`0.05). In both groups, there was a signi®cant ISO-induced increase in fat oxidation, whereas this increase tended to be more pronounced in CON (P`0.001) as compared to NIDDM (P`0.05, Figure 4 ). During ISO-infusion, differences Beta-adrenergic stimulation, obesity and type 2 diabetes EE Blaak et al in fat oxidation per FFM between CON and NIDDM did not reach statistical signi®cance (Figure 4) .
Heart rate signi®cantly increased as result of ISOinfusion in both groups (P`0.001). Resting heart rate (CON:64AE 4 bpm vs NIDDM:69AE 3 bpm) and the ISO-induced increase in heart rate were not signi®-cantly different between groups (at 24 ng CON: 83AE 6 bpm vs NIDDM 90AE 3 bpm).
Discussion
The present study was designed to investigate the sympathetically mediated substrate utilization, thermogenesis and related metabolic responses during badrenergic stimulation in obese subjects with NIDDM. b-adrenergic responses were evaluated by means of a stepwise infusion of increasing doses of the b-agonist ISO (each dose for 30 min). The major ®ndings of the present study are that during ISOinfusion the increase in circulating NEFA levels is blunted in NIDDM, which is accompanied by a tendency towards a less pronounced ISO-induced increase in fat oxidation. Thus, these data provide some evidence for a diminished b-adrenergically mediated fat utilization in obesity-associated NIDDM, as reported before in`simple' obese subjects studied under the same experimental conditions (for data, see Ref 6,  Figure 2 and Table 2 ). These blunted sympathetically mediated responses appear to be of similar magnitude in obese 6 and obese diabetic subjects (compared to the age-matched control groups), indicating that these impairments may be attributed to the obese state per se. Additionally, at rest and during ISO-infusion, adrenalin concentrations were signi®-cantly lowered in obese diabetic subjects, compared to the non-obese control group, whereas in the previous study no differences in adrenalin concentrations could be observed between lean and obese subjects, 6 suggesting that diminished adrenal medullary function may be related to the diabetic state per se.
Previous research has shown that ISO-infusion steps lasting 8 min seem representative of steady state responses for ISO-concentrations, plasma NA, heart rate and lipolytic responses. 16 The present study and previous research 6, 7, 9 have shown representative steady state responses for EE and heart rate after 10 min of infusion. Values for CO 2 production increased more rapidly than O 2 values during the ®rst 10 min of infusion, resulting in an increase in the RER. This effect was most pronounced during the ®rst ISO infusion dose and is most probably due to hyperventilation 17 induced via ISO stimulation of central nervous mechanisms. 18 For this reason, the last 10 min for the oxygen and carbon dioxide exchanges of each infusion period were taken as the response for the administered doses. 9 The blunted capacity to increase NEFA concentrations may be explained by an impaired ISO-induced lipolytic response andaor an increased reesteri®cation within adipose tissue or other tissues. Additionally, super®cial arm vein blood is derived from deep, as well as super®cial, sources, indicating that an increased ISO-induced fractional contribution of blood from subcutaneous adipose tissue in CON may have disturbed the above ®ndings. However, it has previously been shown that the increase in forearm blood¯ow during ISO-infusion is mainly con®ned to forearm skeletal muscle. 6 Secondly, previous data showed that the percentage contribution of forearm subcutaneous adipose tissue blood¯ow to total blood¯ow decreases during ISO-infusion in lean subjects (from 19 ± 12%), whilst no change was observed in obese subjects (11%, Ref 19) , indicating that a greater ISO-induced contribution of subcutaneous adipose tissue blood¯ow to total blood¯ow in CON (as compared to the obese diabetic subjects) does not seem very likely. Finally, an impaired catecholamine induced lipolysis has been reported before in obese subjects and`in vitro' in upper obese subjects with IR and mild NIDDM, 5 strongly indicating that this impaired lipolysis is an important explanation for the blunted increase in NEFA concentrations in NIDDM.
The observed abnormalities in fat utilization of obese diabetic subjects may favour fat storage over oxidation, and so predispose to obesity and IR. However, the overall importance of these ®ndings in the maintenance of a positive fat balance in NIDDM remains to be determined, since basal circulating NEFA levels and fat oxidation were higher in NIDDM, as reported before, 20 resulting in comparable NEFA concentrations and slightly, but not signi®-cantly, different values for fat oxidation (per FFM) during ISO infusion. The fact that basal NEFA concentrations and fat oxidation are higher in NIDDM does not, however, rule out the possibility that the impaired sympathetically mediated fat utilization has contributed to the development of obesity and IR in NIDDM. Since the diminished sympathetically mediated fat utilization is already present in simple obese subjects, 6 it can also be speculated that the increased basal lipolysis rate or fat oxidation in NIDDM develops as a compensation for the decreased stimulatory effect of the sympathetic nervous system. Further research is, however, necessary to elucidate the mechanisms and physiological consequences of these deviations in conditions where the energy utilization of the body is increased.
As in the simple obese group, 6,7 the ISO-induced increase in insulin concentrations was signi®cantly increased in NIDDM, suggesting a possible role of insulin in the diminished increase in NEFA concentrations and the tendency towards a diminished increase in fat oxidation. However, comparable data were reported with adrenalin infusion, where no change was observed in insulin concentrations, 3, 4 Beta-adrenergic stimulation, obesity and type 2 diabetes EE Blaak et al indicating that insulin is not a major determinant of this diminished increase in fat utilization. As indicated above, in vitro studies showed impaired b 2 -adrenergic sensitivity of adipocytes in subjects with upper body obesity and IR or mild NIDDM. 5 Further in vivo research is necessary to elucidate whether the same mechanisms are operative in vivo and in vitro.
An interaction between degree of IR, sympathetic activity and thermogenesis has been suggested. A blunted thermogenic response to cold exposure has been reported in obese diabetic women, 10 indicating an impaired sympathetically mediated thermogenesis in NIDDM. The present study showed no evidence for an impaired b-adrenoceptor stimulated thermogenic response in NIDDM. Also, in the`simple' obese subjects of the previous study, a normal thermogenic response to ISO-infusion was observed. 6 Thus, any previously reported blunted thermogenic response to sympathetic stimulation in NIDDM cannot be explained by a decreased b-adrenergic sensitivity, but may possibly be explained by a decreased NA release by sympathetic nerve endings. Indications in this direction come from a report where a smaller increase in plasma NA, after an oral glucose load, was shown in obese diabetic patients. 21 Basal sympathetic activity, as re¯ected by basal plasma NA concentrations, 22 has been reported to be depressed in diabetic obese patients. 21 Although plasma NA concentrations were lower in NIDDM compared to CON, this difference did not reach statistical signi®cance. Also, the previous study of obese subjects showed normal plasma NA concentrations. 6 ISO-infusion increased venous NA concentrations in a dose dependent manner. This has been reported before and is probably due to a counterregulatory vasoconstrictor re¯ex activated due to ISOinduced vasodilatation. 16 The ISO induced increase in plasma NA was greater in NIDDM, indicating an increased ISO-induced stimulation of NA release from nerve endings in NIDDM. This ®nding opens the possibility that an increased ISO-induced sympathetic activation may have interfered with the comparison of b-adrenergic sensitivity between groups. Although we cannot entirely exclude this possibility, it can be questioned whether thermogenesis and substrate utilization are affected to a great extent by autonomic re¯exes. Moreover, differences between groups were probably too small to be of signi®cance.
As indicated above, at rest and during ISO-infusion adrenaline concentrations were signi®cantly lower in obese diabetic subjects compared to CON, which suggests that adrenal medullary function is reduced in NIDDM. No differences in adrenalin concentrations could be observed between lean and obese subjects in the previous study, 6 suggesting that the lowered venous adrenalin concentrations may be related to the diabetic state per se. Adrenalin de®-ciency in adrenalin secretion may promote an increase in body fatness per se without necessarily affecting body weight, as discussed elsewhere. 23 It is tempting to speculate that a de®ciency in adrenaline secretion may be involved in the etiology of certain types of obesity, affecting both total body fatness and body fat distribution, which makes these individuals prone to the development of IR and diabetes. In this respect, it is of special interest that in vitro studies showed that the impaired sympathetically mediated lipolysis in obesity and NIDDM are due to a defect in b 2 -adrenoceptor sensitivity, for which A is the preferential agonist. However, whether the adrenal medulla plays a role in the regulation of energy metabolism on a daily basis is not yet known. Furthermore, care has to be taken in drawing de®nite conclusions on basis of forearm super®cial venous adrenalin concentrations, since a considerable part of this venous blood may be derived from the forearm muscle and thus may not represent whole body metabolism.
Conclusion
In summary, the present study shows diminished badrenergically mediated fat utilization and lowered plasma adrenalin concentrations in obese diabetic subjects. The disturbances in sympathetically mediated fat utilization have been observed before in obese subjects. 6 The present data require further research, especially in view of the increased basal lipolysis and fat oxidation in obesity-associated NIDDM.
